Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

Clinical trial NCT06524739 · TERMINATED

Trial details

NCT number: NCT06524739
Sponsor: CSL Behring
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-COVID Postural Orthostatic Tachycardia Syndrome

Start date: 2024-08-28
Primary completion: 2025-06-20
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.